INMED PHARMACEUTICALS INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
INMED PHARMACEUTICALS INC. (INM) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $5.10 million as of 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-09-09
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $5.10M.
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $2.70M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2026-06-30 | $5.10M S-4/A · filed 2026-09-09 |
| 2025-06-30 | $2.70M S-4/A · filed 2026-09-09 |
| 2024-06-30 | $3.70M S-4 · filed 2026-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |